148 related articles for article (PubMed ID: 33086573)
1. Anti-Cancer Activity of As
Noh JJ; Kim MS; Cho YJ; Jeong SY; Lee YY; Ryu JY; Choi JJ; Bae I; Wu Z; Kim BG; Hwang JR; Lee JW
Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33086573
[TBL] [Abstract][Full Text] [Related]
2. Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation.
Gwak HS; Park MJ; Park IC; Woo SH; Jin HO; Rhee CH; Jung HW
J Neurosurg; 2014 Dec; 121(6):1483-91. PubMed ID: 25303017
[TBL] [Abstract][Full Text] [Related]
3. Tetraarsenic oxide and cisplatin induce apoptotic synergism in cervical cancer.
Byun JM; Jeong DH; Lee DS; Kim JR; Park SG; Kang MS; Kim YN; Lee KB; Sung MS; Kim KT
Oncol Rep; 2013 Apr; 29(4):1540-6. PubMed ID: 23338680
[TBL] [Abstract][Full Text] [Related]
4. Tetraarsenic hexoxide induces G2/M arrest, apoptosis, and autophagy via PI3K/Akt suppression and p38 MAPK activation in SW620 human colon cancer cells.
Nagappan A; Lee WS; Yun JW; Lu JN; Chang SH; Jeong JH; Kim GS; Jung JM; Hong SC
PLoS One; 2017; 12(3):e0174591. PubMed ID: 28355296
[TBL] [Abstract][Full Text] [Related]
5. Synergistic interaction between tetra-arsenic oxide and paclitaxel in human cancer cells in vitro.
Chung WH; Sung BH; Kim SS; Rhim H; Kuh HJ
Int J Oncol; 2009 Jun; 34(6):1669-79. PubMed ID: 19424586
[TBL] [Abstract][Full Text] [Related]
6. Tetraarsenic hexoxide demonstrates anticancer activity at least in part through suppression of NF-κB activity in SW620 human colon cancer cells.
Lee WS; Yun JW; Nagappan A; Park HS; Lu JN; Kim HJ; Chang SH; Kim DC; Lee JH; Jung JM; Hong SC; Ha WS; Kim G
Oncol Rep; 2015 Jun; 33(6):2940-6. PubMed ID: 25845556
[TBL] [Abstract][Full Text] [Related]
7. [FABP5 promotes cell growth, invasion and metastasis in cervical cancer].
Zhan YZ; Liu F; Zhang Y; Mo XY; Cheng WD; Wang W
Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):200-207. PubMed ID: 30917456
[No Abstract] [Full Text] [Related]
8. [Clinical significance of σ1 receptor over-expression in cervical cancer and the effect of its synthetic ligands on the growth of cervical cancer cells].
Deng YQ; Zhou XH; Jiang LL; Tang XJ; Zhang YX; Cui JQ
Zhonghua Fu Chan Ke Za Zhi; 2017 Jul; 52(7):473-482. PubMed ID: 28797155
[No Abstract] [Full Text] [Related]
9. The cross talk between cervical carcinoma cells and vascular endothelial cells mediated by IL-27 restrains angiogenesis.
Zhang B; Xie F; Dong CL; Gu CJ; Cheng J; Wang Y; Xu XZ; Pu H; Wu YB; Qi XW; Li DJ; Yu JJ; Li MQ
Am J Reprod Immunol; 2017 Oct; 78(4):. PubMed ID: 28508429
[TBL] [Abstract][Full Text] [Related]
10. A nontoxic concentration of cisplatin induces autophagy in cervical cancer: selective cancer cell death with autophagy inhibition as an adjuvant treatment.
Leisching G; Loos B; Botha M; Engelbrecht AM
Int J Gynecol Cancer; 2015 Mar; 25(3):380-8. PubMed ID: 25695544
[TBL] [Abstract][Full Text] [Related]
11. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
Li X; Wang X; Ye H; Peng A; Chen L
Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of autophagy-related protein 6, Beclin-1, decreases cell growth, invasion, and metastasis and has a positive effect on chemotherapy-induced cytotoxicity in osteosarcoma cells.
Zhang W; Li Q; Song C; Lao L
Tumour Biol; 2015 Apr; 36(4):2531-9. PubMed ID: 25427639
[TBL] [Abstract][Full Text] [Related]
13. Arsenic hexoxide enhances TNF-α-induced anticancer effects by inhibiting NF-κB activity at a safe dose in MCF-7 human breast cancer cells.
Kim MJ; Jung JH; Lee WS; Yun JW; Lu JN; Yi SM; Kim HJ; Chang SH; Kim GS; Hong SC; Ha WS
Oncol Rep; 2014 May; 31(5):2305-11. PubMed ID: 24627159
[TBL] [Abstract][Full Text] [Related]
14. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
15. Apatinib, a novel tyrosine kinase inhibitor, suppresses tumor growth in cervical cancer and synergizes with Paclitaxel.
Qiu H; Li J; Liu Q; Tang M; Wang Y
Cell Cycle; 2018; 17(10):1235-1244. PubMed ID: 29886786
[TBL] [Abstract][Full Text] [Related]
16. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
Wei L; Qin XP; Zhao XX; Wang W
Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
[No Abstract] [Full Text] [Related]
17. Comparison of diarsenic oxide and tetraarsenic oxide on anticancer effects: relation to the apoptosis molecular pathway.
Chang HS; Bae SM; Kim YW; Kwak SY; Min HJ; Bae IJ; Lee YJ; Shin JC; Kim CK; Ahn WS
Int J Oncol; 2007 May; 30(5):1129-35. PubMed ID: 17390014
[TBL] [Abstract][Full Text] [Related]
18. Phloretin suppresses metastasis by targeting protease and inhibits cancer stemness and angiogenesis in human cervical cancer cells.
Hsiao YH; Hsieh MJ; Yang SF; Chen SP; Tsai WC; Chen PN
Phytomedicine; 2019 Sep; 62():152964. PubMed ID: 31153059
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
Hougardy BM; van der Zee AG; van den Heuvel FA; Timmer T; de Vries EG; de Jong S
Gynecol Oncol; 2005 May; 97(2):353-64. PubMed ID: 15863130
[TBL] [Abstract][Full Text] [Related]
20. Anti-invasive effect of MMI-166, a new selective matrix metalloproteinase inhibitor, in cervical carcinoma cell lines.
Iwasaki M; Nishikawa A; Fujimoto T; Akutagawa N; Manase K; Endo T; Yoshida K; Maekawa R; Yoshioka T; Kudo R
Gynecol Oncol; 2002 Apr; 85(1):103-7. PubMed ID: 11925127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
